Literature DB >> 20170650

Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes.

Renu A Kowluru1, Qing Zhong, Mamta Kanwar.   

Abstract

Diabetic retinopathy shares many characteristics features of a low grade chronic inflammatory disease. Its progression resists arrest when good metabolic control is re-established after a period of poor metabolic control, suggesting a 'metabolic memory' phenomenon. The aim of this study is to investigate the effect of reversal of high glucose to normal glucose on the inflammatory mediators in pericytes, the site of histopathology in diabetic retinopathy. Bovine retinal pericytes were incubated in high glucose (20 mM) for 2 days followed by normal glucose (5 mM) for 4 days (2 --> 4), or in high glucose for 4 days followed by normal glucose for 4 days (4 --> 4) or 8 days (4 --> 8). Pericytes incubated in continuous normal or high glucose for 2-12 days served as controls. Continuous high glucose exposure for 2-12 days significantly elevated gene expressions and protein concentrations of IL-1 beta, NF-kB, VEGF, TNF-alpha, TGF-beta and ICAM-1 in retinal pericytes. Four days of normal glucose that followed 2 days of high glucose (2 --> 4) had marginal, but significant, beneficial effect on the increases in these inflammatory mediators. Four days of normal glucose in 4 --> 4 group failed to reverse increases in inflammatory mediators and cell apoptosis remained elevated, but addition of dexamethasone during normal glucose exposure ameliorated such increases. However, when normal glucose exposure, after 4 days of high glucose was extended to 8 days (4 --> 8), increases in these mediators were significantly decreased. Hyperglycemia-induced elevations in inflammatory mediators in retinal microvascular cells resist reversal after re-institution of normal glucose conditions. Both, the duration of the initial exposure to high glucose, and normal glucose that follows high glucose, are critical in determining the outcome of the alterations in the inflammatory mediators. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170650      PMCID: PMC2857535          DOI: 10.1016/j.exer.2010.02.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  38 in total

Review 1.  Metabolic memory in diabetes--focus on insulin.

Authors:  Derek LeRoith; Vivian Fonseca; Aaron Vinik
Journal:  Diabetes Metab Res Rev       Date:  2005 Mar-Apr       Impact factor: 4.876

2.  Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.

Authors:  Renu A Kowluru; Sarah Odenbach
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

3.  Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats.

Authors:  Renu A Kowluru
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

4.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy.

Authors:  Renu A Kowluru; Prashant Koppolu
Journal:  Free Radic Res       Date:  2002-09

6.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

7.  Pericytes and the pathogenesis of diabetic retinopathy.

Authors:  Hans-Peter Hammes; Jihong Lin; Oliver Renner; Moshe Shani; Andrea Lundqvist; Christer Betsholtz; Michael Brownlee; Urban Deutsch
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

8.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

Authors:  Neil H White; Wanjie Sun; Patricia A Cleary; Ronald P Danis; Matthew D Davis; Dean P Hainsworth; Larry D Hubbard; John M Lachin; David M Nathan
Journal:  Arch Ophthalmol       Date:  2008-12

9.  Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.

Authors:  M A Ihnat; J E Thorpe; C D Kamat; C Szabó; D E Green; L A Warnke; Z Lacza; A Cselenyák; K Ross; S Shakir; L Piconi; R C Kaltreider; A Ceriello
Journal:  Diabetologia       Date:  2007-05-17       Impact factor: 10.122

10.  Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy.

Authors:  Frederick Pfister; Yuxi Feng; Franziska vom Hagen; Sigrid Hoffmann; Grietje Molema; Jan-Luuk Hillebrands; Moshe Shani; Urban Deutsch; Hans-Peter Hammes
Journal:  Diabetes       Date:  2008-06-16       Impact factor: 9.461

View more
  29 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

2.  Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid.

Authors:  Julia M Santos; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799

Review 3.  Neutrophil transmigration: emergence of an adhesive cascade within venular walls.

Authors:  Mathieu-Benoit Voisin; Sussan Nourshargh
Journal:  J Innate Immun       Date:  2013-03-02       Impact factor: 7.349

4.  Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qian-Yi Lu; Wei Chen; Li Lu; Zhi Zheng; Xun Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy.

Authors:  Jane Yellowlees Douglas; Ashay D Bhatwadekar; Sergio Li Calzi; Lynn C Shaw; Debra Carnegie; Sergio Caballero; Quihong Li; Alan W Stitt; Mohan K Raizada; Maria B Grant
Journal:  Prog Retin Eye Res       Date:  2012-05-15       Impact factor: 21.198

6.  Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells.

Authors:  Rooban B Nahomi; Allison Palmer; Katelyn M Green; Patrice E Fort; Ram H Nagaraj
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 7.  Anti-inflammatory therapy for diabetic retinopathy.

Authors:  Wenbo Zhang; Hua Liu; Modesto Rojas; Robert W Caldwell; Ruth B Caldwell
Journal:  Immunotherapy       Date:  2011-05       Impact factor: 4.196

Review 8.  1,5-Anhydroglucitol in diabetes mellitus.

Authors:  Won Jun Kim; Cheol-Young Park
Journal:  Endocrine       Date:  2012-07-31       Impact factor: 3.633

9.  Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.

Authors:  Cathy Grutzmacher; SunYoung Park; Yun Zhao; Margaret E Morrison; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-17

10.  Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.

Authors:  Esther S Kim; Fumiko Isoda; Irwin Kurland; Charles V Mobbs
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.